The Latest Breaking News from Moderna

While Moderna has outpaced the S&P 500 over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.

Three ETFs with year-to-date performance of 30% or better include a fund focused on drone technology, one targeting nickel miners, and a covered call play.

Oracle stock boosted the tech sector on Friday after the company became co-owner of TikTok's U.S. operations.

Black boxes are the FDA’s most serious warning sign and are usually placed on opioid products

Moderna has continued to underperform the Nasdaq Composite over the past year, and analysts remain cautious about the stock’s prospects.

Despite Nvidia’s strong quarterly performance, the broader market struggled on Thursday. A robust U.S. jobs report, showing non-farm payrolls rising by 119,000 in September, dampened hopes for a December rate cut, as traders now see a 64% chance of the Fed holding rates steady.

Are Wall Street analysts favoring Moderna’s stock?

Moderna Inc. (NASDAQ:MRNA) reported a third-quarter loss of 51 cents, beating the expected loss of $2.02, a turnaround from an income of 3 cents a year ago.

Moderna, Inc (NASDAQ:MRNA) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below. MRNA is building positive momentum. Watch the momentum here This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visithttps://www.benzinga.com/apis/for a consultation. Operator…